Core - classic lines are estimated at 35.0% by product type in 2026, with conventional formulas at 47.0% and liquid & serum formats at 27.0%. Repeat purchase depends on quick absorption and credible treatment value, but fragrance sensitivity and country-specific cosmetic controls raise rollout costs.